Delivery Order SPE2DB20D9766-SPE2DB24FC1ES

Award Date 12/5/23
Potential Completion Date 12/6/23
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $8,993.96 under an indefinite delivery contract with the Defense Logistics Agency to supply Typhim VI 25 mcg/0.5 ml syringes. The delivery order requires DMS Pharmaceutical Group to provide 0.5 ml syringes of Typhim VI, a vaccine, to the Park Ridge, Illinois facility by December 6, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group currently supplies pharmaceuticals and medical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $2,152.50 by the Defense Logistics Agency Troop Support Medical to provide 8503541020 Typhoid VI Polysacc. This delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency, with a potential value of up to $5 million through December 2025. Under the contract, DMS Pharmaceutical Group supplies various pharmaceutical items and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,870 by the Defense Logistics Agency Troop Support Medical to provide 8503633294 Typhoid VI Polysacc. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 by the Defense Logistics Agency Troop Support Medical to provide Typhoid VI polysaccine. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the contract, DMS Pharmaceutical Group supplies pharmaceutical items and medical products to support...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand fifty-four dollars and eighty cents ($1,054.80) by the Defense Logistics Agency Troop Support Medical. The delivery order was awarded on September 4, 2020 for the purpose of providing typhoid VI polysaccine with an expected completion date of September 14, 2020. No set-aside designation was used for this procurement. This delivery order was issued against DMS Pharmaceutical Group's existing...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,054.80 under an indefinite delivery contract with the Defense Logistics Agency to supply 8507899440 Typhoid VI Polysacc. As a woman-owned small business, DMS Pharmaceutical Group provides pharmaceuticals and medical supplies to support Defense Logistics Agency Troop Support Medical facilities. This delivery order will fulfill requirements for the specified vaccine in support of routine immunization programs...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,435 by the Defense Logistics Agency Troop Support Medical to provide 8503525881 Typhoid VI Polysacc. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler,...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 under an indefinite delivery contract with the Defense Logistics Agency to supply typhoid VI polysaccharide vaccine. As a woman-owned small business, DMS Pharmaceutical Group will deliver the vaccines to the Park Ridge, Illinois facility of the Defense Logistics Agency Troop Support Medical organization. This delivery order was issued against DMS Pharmaceutical Group's existing pharmaceutical prime...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 under an indefinite delivery contract with the Defense Logistics Agency to supply Typhoid VI polysaccharide vaccine in support of military treatment facilities. As a woman-owned small business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds numerous contracts with the Defense Logistics Agency Troop Support Medical to provide various pharmaceutical and medical supply items....
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,689.90 under an indefinite delivery contract with the Defense Logistics Agency to supply typhoid VI polysaccine. The delivery order was awarded on November 27, 2022 with a completion date of December 7, 2022. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc. will fulfill the order as the prime contractor, supplying the requested typhoid VI polysaccine to Defense Logistics...
  • SPE2DB20D9766
    Indefinite Delivery Contract
  • SPE2DB20D9766-SPE2DB24FC1ES
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-four thousand eight hundred six dollars by the Defense Logistics Agency to provide Typhim VI 25 mcg/0.5 ml vials. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical Group will deliver the Typhim VI vials to support military treatment facilities operated by the Defense Logistics Agency.

Generated 3/5/24, 7:12 PM